With the news that the CDC is pausing J&J vaccine distribution due to blood clot issues.
I'm assuming we should see it tank at the open? You're guess is as good as mine.
In my opinion if we see price drop it should be a good time to buy, because everyone else is selling.
The level I'm interested in is $147-$150.
It is an untested point of control where institutions may have some buy orders sitting.
Watch for an ABCD on the line chart (close to close) for entry.
We may not break the 2021 high, but if the March equal highs remain untouched, I would look to enter because there is still possibly liquidity there.
$150 should give a nice reaction if we hit it while those highs are untouched.
Let's Elevate,
Gio
I'm assuming we should see it tank at the open? You're guess is as good as mine.
In my opinion if we see price drop it should be a good time to buy, because everyone else is selling.
The level I'm interested in is $147-$150.
It is an untested point of control where institutions may have some buy orders sitting.
Watch for an ABCD on the line chart (close to close) for entry.
We may not break the 2021 high, but if the March equal highs remain untouched, I would look to enter because there is still possibly liquidity there.
$150 should give a nice reaction if we hit it while those highs are untouched.
Let's Elevate,
Gio
Each week, I send an email breakdown of the best forex setups, watch zones, and market trends so you can trade with confidence.
Your next setup is waiting—Subscribe for access to my weekly outlooks.
Your next setup is waiting—Subscribe for access to my weekly outlooks.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Each week, I send an email breakdown of the best forex setups, watch zones, and market trends so you can trade with confidence.
Your next setup is waiting—Subscribe for access to my weekly outlooks.
Your next setup is waiting—Subscribe for access to my weekly outlooks.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.